Answers are grounded in this paper and cite their sources.
Randomized trials reveal multifactorial risk factors for weight gain during antiretroviral therapy initiation, highlighting complex interactions between demographics, HIV status, and drug regimens.
Weight gain is ubiquitous in clinical trials of ART initiation and is multifactorial in nature, with demographic factors, HIV-related factors, and the composition of ART regimens as contributors. The mechanisms by which certain ART agents differentially contribute to weight gain are unknown.
No takes yet. Share an insight, caveat, or question.
Sax et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: